Antibiotics and Bacterial Resistance: An Emerging Challenge in the Management of Urinary Tract Infections

This article was exclusively written for European Sting by Ms. Mariana Pioltine Murari, a third-year student at the Fac/ulty of Health Sciences of Barretos Dr. Paulo Prata (FACISB). She is affiliated with the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view on the topic, nor The European Sting’s one.

Antibiotics were introduced in the early twentieth century following an accidental laboratory discovery, in which a fungus unintentionally grew in a bacterial culture and inhibited its proliferation. This event led to the identification of penicillin and marked the beginning of a new era in modern medicine. From this milestone, extensive research efforts were directed toward the development of antibiotics capable of exerting targeted activity against specific bacterial groups. Over subsequent decades, scientific progress enabled the creation of multiple antibiotic classes, each characterized by distinct mechanisms of action and directed toward defined pathogenic organisms. In recent years, however, the indiscriminate and inappropriate use of these agents has contributed significantly to the global rise of antimicrobial resistance. This phenomenon occurs when the most resilient bacterial strains survive antimicrobial exposure and subsequently predominate, becoming unresponsive to treatments that were once clinically effective. As a result, an environment conducive to the dissemination of multidrug-resistant microorganisms has been established, posing a substantial threat to public health.

Within the context of urinary tract infections (UTIs), this issue acquires particular relevance. UTIs represent one of the most common infectious conditions worldwide, affecting millions of individuals annually. Due to the frequent recurrence of symptoms and the widespread availability of antibiotics, many individuals initiate treatment without appropriate clinical guidance, thereby promoting the selection and spread of resistant bacterial strains. Current evidence demonstrates that the empirical and repeated use of antimicrobials has increased resistance among common uropathogens, particularly Escherichia coli, subsequently complicating therapeutic management and elevating rates of recurrence, complications, and hospital admissions. Importantly, the burden of antimicrobial resistance disproportionately affects low-income and socially vulnerable populations, who often face limited access to proper healthcare, diagnostic services, and adequate treatment options, further exacerbating health inequalities.

In light of this scenario, advancing the understanding of antimicrobial resistance mechanisms and reinforcing the rational use of antibiotics are essential strategies for preserving therapeutic efficacy, particularly in highly prevalent conditions such as UTIs. The adoption of comprehensive health education initiatives, coupled with accurate diagnostic approaches and responsible prescribing practices, remains fundamental to mitigating the spread of resistant microorganisms. Such measures not only safeguard individual patient outcomes but also strengthen collective public health efforts in addressing this escalating global challenge.

About the author

Mariana Pioltine Murari is a third-year student at the Faculty of Health Sciences of Barretos Dr. Paulo Prata (FACISB). She serves as the coordinator of the SCOPH – Standing Committee on Public Health – within IFMSA.